These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 356551)

  • 21. [Clinical evaluation of a new drug (Aprindine) on ventricular and superventricular arrhythmia].
    Villalobos Galán E; Martin Santos F; Fernández Corral E; de Elio Membrado FJ
    Rev Clin Esp; 1975 Sep; 138(5):461-8. PubMed ID: 1178995
    [No Abstract]   [Full Text] [Related]  

  • 22. [Experience with mexiletine in the occurrence of ventricular arrhythmias in the acute phase of myocardial infarct].
    Koller H; Prager H; Sterz H
    Adv Clin Pharmacol; 1978; 16():71-3. PubMed ID: 685751
    [No Abstract]   [Full Text] [Related]  

  • 23. Long term treatment of ventricular arrhythmias with oral mexiletine.
    Campbell RW; Julian DG; Talbot RG; Prescott LF
    Postgrad Med J; 1977; 53 Suppl 1():146-9. PubMed ID: 406605
    [No Abstract]   [Full Text] [Related]  

  • 24. [Anti-arrhythmic efficacy of the amiodarone-mexiletine combination in the treatment of resistant complex ventricular arrhythmias].
    Purcaro A; Massacci C; Curzi G; Pigini G; Costantini C; Bilancini A; Blandini A
    G Ital Cardiol; 1986 May; 16(5):417-26. PubMed ID: 3732727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Experience with mexiletin in the treatment of ventricular arrhythmias (author's transl)].
    Kána A; Florcíková L; Jurecková A; Klabusay L; Simícek J; Tomecková A
    Cas Lek Cesk; 1980 Jan; 119(1):14-7. PubMed ID: 7371049
    [No Abstract]   [Full Text] [Related]  

  • 26. [Mexiletin for treatment of ventricular ectopic rhythm in patients with acute myocardial infarction (author's transl)].
    Merx W; Franken G; Brunner H; Effert S; Henning B
    Z Kardiol; 1980 Apr; 69(4):262-7. PubMed ID: 7006236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of arrhythmias with high risk of sudden death in chronic Chagas' cardiopathy with oral mexiletine. Evaluation with 24-hour ambulatory electrocardiographic monitoring (Holter)].
    Sgammini HO; Evequoz MC; Chuit R; Atti R; Santamarina NO; Kuschnir E
    Arq Bras Cardiol; 1983 Feb; 40(2):103-9. PubMed ID: 6354146
    [No Abstract]   [Full Text] [Related]  

  • 28. Mexiletine for ventricular arrhythmia after repair of tetralogy of Fallot.
    Malcolm ID; Stubington D; Gibbons JE
    Can Med Assoc J; 1980 Sep; 123(6):530-2. PubMed ID: 7437974
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of disopyramide and aprindine on arrhythmias after acute myocardial infarction.
    Pouleur H; Chaudron JM; Reyns P
    Eur J Cardiol; 1977 Jul; 5(5):397-404. PubMed ID: 330168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Ventricular heart-rhythm disorders - sudden cardiac death: results of long-term drug therapy].
    Lüderitz B; Manz M; Steinbeck G
    Verh Dtsch Ges Herz Kreislaufforsch; 1983; 49():209-17. PubMed ID: 6666303
    [No Abstract]   [Full Text] [Related]  

  • 31. The development of mexiletine in the management of ventricular dysrhythmias.
    Campbell NP; Chaturvedi NC; Shanks RG; Kelly JG; Strong JE; Adgey AA
    Postgrad Med J; 1977; 53 Suppl 1():114-9. PubMed ID: 69297
    [No Abstract]   [Full Text] [Related]  

  • 32. [Monitoring of anti-arrhythmia drugs with the Holter system and the determination of their blood levels (mexiletine (mexitil) and amiodarone)].
    Paciaroni E; Ferroni C; Marini M; Campanari G
    Minerva Cardioangiol; 1985 May; 33(5):251-8. PubMed ID: 4033966
    [No Abstract]   [Full Text] [Related]  

  • 33. [Mexiletine in the treatment of ventricular rhythm disorders].
    Schlemmer M; Wimmer M
    Monatsschr Kinderheilkd; 1982 Jun; 130(6):512-3. PubMed ID: 7133009
    [No Abstract]   [Full Text] [Related]  

  • 34. Ventricular arrhythmias after acute myocardial infarction treated with procainamide or mexiletine.
    Campbell RW; Dolder MA; Prescott LF; Talbot RG; Murray A; Julian DG
    Postgrad Med J; 1977; 53 Suppl 1():150-3. PubMed ID: 327453
    [No Abstract]   [Full Text] [Related]  

  • 35. [Experience with 7 year use of mexitil].
    Smolenskiĭ VS; Fomina IG; Iankin VV; Kolpakov EV; Morgunov NB
    Klin Med (Mosk); 1985 Aug; 63(8):48-52. PubMed ID: 3908809
    [No Abstract]   [Full Text] [Related]  

  • 36. Long-term oral antiarrhythmic therapy with aprindine: effects on cardiac function and adverse effects.
    Tsutsui H; Araki H; Nagata Y; Nakamura M
    Clin Ther; 1984; 6(6):770-7. PubMed ID: 6509460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Anti-arrhythmic effects of mexiletine].
    Ledain L; Page A; Favreau L; Besse P
    Arch Mal Coeur Vaiss; 1982 May; 75(5):605-12. PubMed ID: 6180692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disopyramide and mexiletine: which is the agent of choice in the long term-oral treatment of lidocaine-responsive arrhythmias? Efficacy comparison in a randomized trial.
    Trimarco B; Volpe M; Ricciardelli B; Sacca' L; De Luca N; Rengo F; Condorelli M
    Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):251-9. PubMed ID: 7013721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Méxiletine. Action on heart rhythm disorders].
    Lellouche D; Bougherbal R
    Nouv Presse Med; 1975 Feb; 4(5):351-2. PubMed ID: 1093125
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparative study of the antiarrhythmic efficacy of mexiletine and disopyramide in patients with chronic ventricular arrhythmias.
    Breithardt G; Seipel L; Lersmacher J; Abendroth RR
    J Cardiovasc Pharmacol; 1982; 4(2):276-84. PubMed ID: 6175812
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.